Pfizer IncChange company Symbol lookupSelect an option...PFE Pfizer IncGIIXU Gores Holdings VIII IncGIL Gildan Activewear IncSAFM Sanderson Farms IncEYPT EyePoint Pharmaceuticals IncNKRKY Nokian Tyres plcUSEG US Energy CorpRENO Renovare Environmental IncCRT Cross Timbers Royalty TrustLUV Southwest Airlines CoGo
Change company Symbol lookup
Select an option...
PFE Pfizer Inc
GIIXU Gores Holdings VIII Inc
GIL Gildan Activewear Inc
SAFM Sanderson Farms Inc
EYPT EyePoint Pharmaceuticals Inc
NKRKY Nokian Tyres plc
USEG US Energy Corp
RENO Renovare Environmental Inc
CRT Cross Timbers Royalty Trust
LUV Southwest Airlines Co
Health Care : Pharmaceuticals | Large Cap Value
Company profilePfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The Company offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of immuno-inflammatory diseases, including ulcerative colitis, Crohn’s Disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. The Company works across markets to develop wellness, prevention, treatments and cures. It collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. The Company's medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness.
|
|
|
|
| |
| Latest Earnings Beat Consensus (Q1 ending 03/2022) | Next Earnings Announcement | ||||||
|---|---|---|---|---|---|---|---|
| Q1 Non-GAAP earnings GAAP vs. Non-GAAP EarningsTD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Announced May 3, 2022 | $1.67 | Q1 Consensus of 15 analysts | $1.47 | Difference from consensus | 13.30% | Q2 Earnings will announce | (Unconfirmed) July 26, 2022 |
Quarterly Earnings History and Estimates
Show high-low estimates
Draw trendlines
Draw up to 3 lines inside the chart.
PFE's fiscal year ends in December
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2022. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.